Kenneth A. Lock Insider Trading $ARQT Arcutis Biotherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kenneth A. Lock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kenneth A. Lock. Kenneth A. Lock is Chief Commercial Officer in Arcutis Biotherapeutics, Inc. ($ARQT).
Kenneth A. Lock in Arcutis Biotherapeutics, Inc.
Trading Symbol: ARQTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth A. Lock: Chief Commercial Officer
Holdings: 31,667 shares
Latest Transaction: Mar 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Kenneth A. Lock in Arcutis Biotherapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Grant | A | 0.00 | 9,500 | 0 | 31,667 | 22.2 K to 31.7 K (+42.86 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Sell | S | 34.20 | 933 | 31,908 | 22,167 | 23.1 K to 22.2 K (-4.04 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Sell | S | 34.20 | 933 | 31,908 | 22,167 | 23.1 K to 22.2 K (-4.04 %) |
Oct 27 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | M | 6.52 | 2,668 | 17,395 | 147,080 | |
Oct 27 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Buy | M | 6.52 | 2,668 | 17,395 | 21,863 | 19.2 K to 21.9 K (+13.90 %) |
Oct 23 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | M | 6.52 | 2,695 | 17,571 | 149,748 | |
Oct 23 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Buy | M | 6.52 | 2,695 | 17,571 | 19,195 | 16.5 K to 19.2 K (+16.33 %) |
Oct 16 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | M | 6.52 | 7,500 | 48,900 | 152,443 | |
Oct 16 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Buy | M | 6.52 | 7,500 | 48,900 | 16,500 | 9 K to 16.5 K (+83.33 %) |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | A | 27.61 | 27,000 | 745,470 | 27,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
Page: 1